Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Matthew Harkenrider"'
Autor:
Alexander Harris, Mark Korpics, Zohaib Sherwani, Ahmer Farooq, Kristin Baldea, Robert Flanigan, Matthew Harkenrider, Abhishek Solanki
Publikováno v:
Journal of Contemporary Brachytherapy, Vol 12, Iss 3, Pp 216-224 (2020)
Externí odkaz:
https://doaj.org/article/c5bb14cac8a648fea66dd4a4db448edc
Autor:
Raymond B. Mailhot Vega, David Barbee, Wesley Talcott, Tamara Duckworth, Bhartesh A. Shah, Omar F. Ishaq, Christina Small, Anamaria R. Yeung, Carmen A. Perez, Peter B. Schiff, Ophira Ginsburg, William Small Jr, May Abdel-Wahab, Gustavo Sarria Bardales, Matthew Harkenrider
Publikováno v:
Journal of Contemporary Brachytherapy, Vol 10, Iss 6, Pp 503-509 (2018)
Externí odkaz:
https://doaj.org/article/335aeecb3db94a95b50e07b4d2998ef0
Autor:
Tracy, Sherertz, Anuja, Jhingran, Matthew, Biagioli, David, Gaffney, Mohamed, Elshaikh, Robert L, Coleman, Matthew, Harkenrider, Elizabeth A, Kidd, Shruti, Jolly, Catheryn, Yashar, Lorraine, Portelance, Andrew, Wahl, Aradhana, Venkatesan, Linna, Li, William, Small
Publikováno v:
International Journal of Gynecologic Cancer. 32:1549-1554
BackgroundUterine clear cell and serous carcinomas have a high propensity for locoregional and distant spread, tend to be more advanced at presentation, and carry a higher risk of recurrence and death than endometrioid cancers. Limited prospective da
Autor:
John Michael Varlotto, Zhuoxin Sun, Bonnie Ky, Jenica Upshaw, Thomas J. Fitzgerald, Max Diehn, Christine Lovly, Chandra Belani, Kurt Oettel, Gregory Masters, Matthew Harkenrider, Helen Ross, Suresh Ramalingam, Nathan A. Pennell
Publikováno v:
Clinical Lung Cancer. 23:547-560
ECOG-ACRIN EA5181 is a current prospective, randomized trial that is investigating whether the addition of concomitant durvalumab to standard chemo/radiation followed by 1 year of consolidative durvalumab results in an overall survival benefit over s
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 112:841-848
Autor:
Lindsay Burt, Jessica Huang, Ken Boucher, Gita Suneja, Cristina Decesaris, Jonathan Grant, Matthew Harkenrider, Anuja Jhingran, Elizabeth Kidd, Lilie Lin, William Small, David Gaffney
Publikováno v:
Focused Plenary Abstracts.
Autor:
Matthew Harkenrider, Emma Fields, Supriya Chopra, Shari Damast, Elizabeth A. Kidd, Junzo Chino
Publikováno v:
International journal of radiation oncology, biology, physics. 115(2)
Publikováno v:
Cureus.
Radiation pneumonitis (RP) is a local inflammatory response, and we hypothesize that RP serves as an immune stimulator and is a protective factor against disease progression. Methods: We analyzed patients with early-stage non-small cell lung cancer (
Autor:
Alexander Podgorsak, Bhanu Prasad Venkatesulu, Mohammed Abuhamad, Matthew Harkenrider, Abhishek Solanki, John Roeske, Hyejoo Kang
Publikováno v:
Brachytherapy. 21:S32
Autor:
Shari Damast, Matthew Harkenrider, Junzo Chino, Kevin Albuquerque, Elizabeth Kidd, Mitchell Kamrava
Publikováno v:
J Clin Oncol
PURPOSE: In oncology trials, the National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE) is the standard tool for reporting adverse events (AEs), but it may underreport symptoms experienced by patients. This analysis of the N